Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Implant Wear Reduction Targeted By Biomet To Allow More Hip Replacements

This article was originally published in The Gray Sheet

Executive Summary

Biomet is rolling out two hip implant offerings this year with reduced risk of device wear, which orthopedic surgeons consider a critical barrier to replacement procedures

You may also be interested in...



Ortho Firms Should Begin Strategizing For EU Reclassification – BSI’s Brooks

Manufacturers should start submitting design dossiers to notified bodies for their hip, knee and shoulder replacements to be reclassified as Class III devices in the European Union, according to BSI Americas VP Paul Brooks

Ortho Firms Should Begin Strategizing For EU Reclassification – BSI’s Brooks

Manufacturers should start submitting design dossiers to notified bodies for their hip, knee and shoulder replacements to be reclassified as Class III devices in the European Union, according to BSI Americas VP Paul Brooks

Biomet Urges Medicare Coding Revision For “Complex” Joint Replacement

CMS should create separate diagnosis-related groups (DRGs) for revision hip and knee surgeries, according to Biomet

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021684

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel